Stryker, MacMillan reach deal on severance; AccessClosure launches MynxGrip vascular closure device;

@FierceMedDev: AngioDynamics' new chief playing offense and ready for risk. Via @Business_Review. Article | Follow @FierceMedDev

> Former Stryker ($SYK) CEO Stephen MacMillan will get $5.5 million in cash, plus the rights to purchase up to $65 million worth of company stock, as part of his separation agreement. News

> AccessClosure has scored FDA approval and launched the MynxGrip vascular closure device. AccessClosure release

> University of Massachusetts Medical School and MIT researchers are working on technologies that will one day allow cellphones to automatically detect and intervene when a person suffering from post-traumatic stress disorder or substance abuse problems needs support. Item

> Abbott Labs ($ABT) is working with the University of North Texas Science Center to evaluate the company's PLEX-ID instrument for use in analyzing human remains to support missing persons and human trafficking investigations. Abbott Labs release

> Molnlycke Health Care US has acquired the assets of Brennen Medical's burn and wound care business. Release

> Chinese doctors have implanted the first Teligen ICDs from Boston Scientific ($BSX) in that country. The Chinese State Food and Drug Administration approved the Teligen family of devices in November. Boston Scientific release

And Finally... UCLA researchers have developed a new cellphone-based fluorescent imaging and sensing platform that can detect E. coli in food and water. News

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.